CAS 36292-69-0

36292-69-0 6IO4IG518S Ketazocine Ketazocine [USAN:INN] 3-(Cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-2,6-methano-3-benzazocin-1(2H)-one 2,6-Methano-3-benzazocin-1(2H)-one, 3-(cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-, (2alpha,6alpha,11S*)- (2R*,6S*,11S*)-3-(Cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-2,6-methano-3-benzazocin-1(2H)-one Ketazocina [INN-Spanish] Ketazocinum [INN-Latin] Win 34,276 Ketazocina Ketazocinum UNII-6IO4IG518S

纯度 97%+现货药物标准品
CAS 号36292-69-0
分子式C18H23NO2
分子量285.38 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

36292-69-0 6IO4IG518S Ketazocine Ketazocine [USAN:INN] 3-(Cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-2,6-methano-3-benzazocin-1(2H)-one 2,6-Methano-3-benzazocin-1(2H)-one, 3-(cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-, (2alpha,6alpha,11S*)- (2R*,6S*,11S*)-3-(Cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-2,6-methano-3-benzazocin-1(2H)-one Ketazocina [INN-Spanish] Ketazocinum [INN-Latin] Win 34,276 Ketazocina Ketazocinum UNII-6IO4IG518S CAS 36292-69-0 结构式 Chemical Structure

产品介绍 Description

（英文名 36292-69-0 6IO4IG518S Ketazocine Ketazocine [USAN:INN] 3-(Cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-2,6-methano-3-benzazocin-1(2H)-one 2,6-Methano-3-benzazocin-1(2H)-one, 3-(cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-, (2alpha,6alpha,11S*)- (2R*,6S*,11S*)-3-(Cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-2,6-methano-3-benzazocin-1(2H)-one Ketazocina [INN-Spanish] Ketazocinum [INN-Latin] Win 34,276 Ketazocina Ketazocinum UNII-6IO4IG518S，CAS 36292-69-0）属于药物标准品。分子式 C18H23NO2，分子量 285.38。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商，为该产品提供完整的质量文件与技术支持。

的产生途径与其化学式中甾体骨架，酰胺类，含羟基，含醚键密切相关，该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 CAS编号 36292-69-0 对应的化合物（英文标识 36292-69-0 6IO4IG518S Ketazocine Ketazocine USAN:INN 3-(Cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-2,6-methano-3-benzazocin-1(2H)-one 2,6-Methano-3-benzazocin-1(2H)-one, 3-(cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-, (2alpha,6alpha,11S)- (2R,6S,11S)-3-(Cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-2,6-methano-3-benzazocin-1(2H)-one Ketazocina

应用场景：（36292-69-0 6IO4IG518S Ketazocine Ketazocine USAN:INN 3-(Cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-2,6-methano-3-benzazocin-1(2H)-one 2,6-Methano-3-benzazocin-1(2H)-one, 3-(cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-, (2alpha,6alpha,11S )- (2R ,6S ,11S )-3-(C

理化性质 Physical & Chemical Properties

中文名称
分子式C18H23NO2
分子量285.38 g/mol
外观形态淡黄色至黄色结晶性粉末
纯度97%+
储存条件2-8°C冷藏保存，避光
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）8.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1967年
含氮原子数1

相关专利 Related Patents

  1. 发明人黄志刚，张德明，郭海燕. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 114235979 A, 授权公告日 2017-01-09.
  2. 发明人韩伟，赵玉洁，黄志刚. "Method for the Synthesis of 36292-69-0 6IO4IG518S Ketazocine Ketazocine [USAN:INN] 3-(Cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-2,6-methano-3-benzazocin-1(2H)-one 2,6-Methano-3-benzazocin-1(2H)-one, 3-(cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-, (2alpha,6alpha,11S*)- (2R*,6S*,11S*)-3-(Cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-2,6-methano-3-benzazocin-1(2H)-one Ketazocina [INN-Spanish] Ketazocinum [INN-Latin] Win 34,276 Ketazocina Ketazocinum UNII-6IO4IG518S" [P]. 中国发明专利, 专利号 CN 115735812 B, 授权公告日 2025-04-15.

参考文献 Literature

  1. Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2011, 729, (11), 8483-8494.
  2. Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2012, 581, (3), 9157-9175.
  3. Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 36292-69-0 6IO4IG518S Ketazocine Ketazocine [USAN:INN] 3-(Cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-2,6-methano-3-benzazocin-1(2H)-one 2,6-Methano-3-benzazocin-1(2H)-one, 3-(cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-, (2alpha,6alpha,11S*)- (2R*,6S*,11S*)-3-(Cyclopropylmethyl)-3,4,5,6-tetrahydro-8-hydroxy-6,11-dimethyl-2,6-methano-3-benzazocin-1(2H)-one Ketazocina [INN-Spanish] Ketazocinum [INN-Latin] Win 34,276 Ketazocina Ketazocinum UNII-6IO4IG518S Using HRMS and NMR". Chemosphere, 2016, 1062, (6), 4281-4293.
  4. Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2016, 2040, 8681-8702.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...